Correlation Between Acer Therapeutics and Acorda Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acer Therapeutics and Acorda Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acer Therapeutics and Acorda Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acer Therapeutics and Acorda Therapeutics, you can compare the effects of market volatilities on Acer Therapeutics and Acorda Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acer Therapeutics with a short position of Acorda Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acer Therapeutics and Acorda Therapeutics.

Diversification Opportunities for Acer Therapeutics and Acorda Therapeutics

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Acer and Acorda is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Acer Therapeutics and Acorda Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acorda Therapeutics and Acer Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acer Therapeutics are associated (or correlated) with Acorda Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acorda Therapeutics has no effect on the direction of Acer Therapeutics i.e., Acer Therapeutics and Acorda Therapeutics go up and down completely randomly.

Pair Corralation between Acer Therapeutics and Acorda Therapeutics

If you would invest  1,210  in Acorda Therapeutics on January 26, 2024 and sell it today you would lose (1,155) from holding Acorda Therapeutics or give up 95.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy7.14%
ValuesDaily Returns

Acer Therapeutics  vs.  Acorda Therapeutics

 Performance 
       Timeline  
Acer Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acer Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Acer Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Acorda Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Acorda Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively weak basic indicators, Acorda Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Acer Therapeutics and Acorda Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acer Therapeutics and Acorda Therapeutics

The main advantage of trading using opposite Acer Therapeutics and Acorda Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acer Therapeutics position performs unexpectedly, Acorda Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acorda Therapeutics will offset losses from the drop in Acorda Therapeutics' long position.
The idea behind Acer Therapeutics and Acorda Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Valuation
Check real value of public entities based on technical and fundamental data
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk